celecoxib has been researched along with Parkinsonian Disorders in 2 studies
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, R | 1 |
| Thota, S | 1 |
| Bansal, R | 1 |
| Moghaddamt, HF | 1 |
| Ardestani, MS | 1 |
| Saffari, M | 1 |
| Navidpour, L | 1 |
| Shafiee, A | 1 |
| Rahmim, A | 1 |
2 other studies available for celecoxib and Parkinsonian Disorders
| Article | Year |
|---|---|
Studies on 16,17-Pyrazoline Substituted Heterosteroids as Anti-Alzheimer and Anti-Parkinsonian Agents Using LPS Induced Neuroinflammation Models of Mice and Rats.
Topics: Alzheimer Disease; Animals; Antiparkinson Agents; Brain; Celecoxib; Dexamethasone; Drug Evaluation, | 2018 |
Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective cyclooxygenase-2 inhibition in normal and hemiparkinsonian rats.
Topics: Animals; Celecoxib; Corpus Striatum; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors | 2008 |